Novel transcript, antisense to CLCN3

Novel transcript, antisense to CLCN3" designates a long non-coding RNA (lncRNA) molecule transcribed from the DNA strand opposite the CLCN3 gene. Antisense lncRNAs are widespread in eukaryotic genomes and can influence the expression of their sense counterparts (such as CLCN3) by altering the local chromatin environment, modifying the rate of sense transcription, processing, or stability[1]. However, there is no evidence that this particular antisense transcript functions as a drug or therapeutic target, nor that it encodes a protein or is involved in direct disease mechanisms. Most current evidence indicates that the principal function of such non-coding antisense transcripts is in epigenetic or transcriptional regulation, rather than acting as traditional protein-coding targets[1][5]. This molecule cannot be classified as a receptor, enzyme, transporter, or well-established druggable target. Its biological significance, if any, likely derives from modulation of CLCN3 gene expression rather than direct molecular or pharmacological intervention.

Other names

Novel transcript antisense to CLCN3ENSG00000303876